New brain test aims to unravel language confusion in dementia
NCT ID NCT07573046
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new cognitive assessment called the ExéSem battery, designed to help doctors tell the difference between language problems caused by memory loss versus those caused by thinking difficulties. Researchers will enroll 140 people, including those with Alzheimer's disease, vascular cognitive impairment, a specific language disorder, and healthy volunteers. Participants will complete tasks like matching words to pictures and naming objects quickly, with results used to see if the battery can accurately identify the root cause of language issues.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ExéSem cognitive battery (a neuropsychological assessment tool)
What this could lead to
If successful, this battery could help doctors more accurately diagnose whether language problems are due to memory loss or thinking difficulties.
What could go wrong
This is an early validation study, not a treatment trial. The battery may not prove reliable enough for widespread use, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital des CHARPENNES ( Hospices Civils de Lyon)
Lyon, 69100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••